Psychopharmacology Bulletin, V47, N3: Links to In-Depth Articles

Psychopharmacology Bulletin,

V47, N3: Links to In-Depth Articles

ORIGINAL PRESENTATIONS

Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder. By Brianne Brown, Larry Alphs, Ibrahim Turkoz, Yong Yue

Correlation of Caregiver Burden and Baseline Characteristics of Caregivers and Patients in Their Care with Recent-Onset Psychosis: The FIRST Study. By Branislav Mancevski, Jagadish Gogate, Katie Ashcroft, Kristy Tardieu, Ed Kim

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil. By Robert Risinger, Marjie Hard, Peter J. Weiden

Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil. By Henry A. Nasrallah, Ralph Aquila, Arielle D. Stanford, Hasan H. Jamal, Peter J. Weiden, Robert Risinger

Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects. By Rosa Luo, Haig Bozigian, Roland Jimenez, Gordon Loewen, Christopher F. O’Brien

Efficacy of Valbenazine in Treating Subjects with Tardive Dyskinesia and Mood Disorder. By Christoph U. Correll, Richard C. Josiassen, Grace S. Liang, Joshua Burke, Christopher F. O’Brien

Long-Term Safety and Tolerability of Valbenazine in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder. By Richard C. Josiassen, John M. Kane, Grace S. Liang, Joshua Burke, Christopher F. O’Brien

Efficacy of Valbenazine in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder. By John M. Kane, Christoph U. Correll, Grace S. Liang, Joshua Burke, Christopher F. O’Brien

CLINICAL EDUCATIONAL REVIEW

Reference Guide Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia

By James La Rossa|2021-11-11T17:06:52-08:00August 9th, 2017|Brief Bulletins from the Field, We Know Psychiatry|0 Comments

About the Author: James La Rossa

Leave A Comment Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.